Pre-clinical study suggests path toward non-addictive painkillers
A pre-clinical study reports that the use of the positive allosteric modulator GAT211 enhances the effect of pain-relief chemicals produced by the body in response to stress or injury. The research is a promising step forward in the search for pain relief methods without the addictive side effects of opioids. …read more
